Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
D015073:2-Acetylaminofluorene / Q000494:pharmacology; D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D002455:Cell Division; D003043:Cocarcinogenesis; D004052:Diethylnitrosamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006984:Hypertrophy; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000139:chemically induced*; D008862:Microsomes, Liver / Q000201:enzymology; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009929:Organ Size / Q000187:drug effects; D010105:Oxygenases / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology*; D011230:Precancerous Conditions / Q000139:chemically induced*; D051381:Rats
D002273:Carcinogens; D004052:Diethylnitrosamine; D015073:2-Acetylaminofluorene; D010105:Oxygenases; D010634:Phenobarbital